• Home
• Responsibility
• CR Report 2004
• Access to medicines

Access to medicines

Access to healthcare is a significant challenge in many parts of the world. Millions of poor people in both developed and developing countries cannot obtain the medicines they need.

This section describes how GSK is helping to improve access, and our progress in 2004. It covers our:

• contribution to the developing world through research, not-for-profit pricing, partnerships and voluntary licences;
• preferential pricing arrangements and discount cards for middle-income countries;
• Patient Assistance Programs and discount cards to help uninsured patients in the US.

We also support under-served communities worldwide through donations, funding and practical support, see Community investment.

Back to top